跳至主要内容
临床试验/DRKS00030574
DRKS00030574招募中不适用

Biomarkers of thrombocyte activation as predictive factor for hemorrhagic complications of strokes occurring under platelet aggregation inhibition - PSC-BAT (Predicting Stroke Complications - Biomarker of Activated Thrombocytes)

Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität0 个研究点目标入组 100 人开始时间: 2023年1月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Clincal and/or radiological diagnosis of an acute ischemic or hemorrhagic stroke
  • - Time from symptom onset or last seen well to hospital admission <24h
  • - Prior antithrombotic medication (aspirin, clopidogrel, ticagrelor, prasugrel, dipyridamol) or lack thereof (control group)

排除标准

  • - Prior oral anticoagulation (marcumar, dabigatran, apixaban, rivaroxaban, edoxaban) or heparin
  • - Administration of intravenous thromboylsis prior to blood test
  • - History of coagulation disorders (e.g. von Willebrand disease, Glanzmann`s thrombasthenia, Bernard-Soulier syndrome)

研究者

发起方
Klinik für Neurologie, Universitätsklinikum Frankfurt, Goethe Universität

相似试验

Biomarkers of thrombocyte activation as predictive... | 临床试验